Log in to save to my catalogue

1239. Ceftaroline versus Vancomycin as First-Line Therapy for MRSA Bacteremia

1239. Ceftaroline versus Vancomycin as First-Line Therapy for MRSA Bacteremia

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8644109

1239. Ceftaroline versus Vancomycin as First-Line Therapy for MRSA Bacteremia

About this item

Full title

1239. Ceftaroline versus Vancomycin as First-Line Therapy for MRSA Bacteremia

Publisher

US: Oxford University Press

Journal title

Open forum infectious diseases, 2021-12, Vol.8 (Supplement_1), p.S709-S709

Language

English

Formats

Publication information

Publisher

US: Oxford University Press

Subjects

Subjects and topics

More information

Alternative Titles

Full title

1239. Ceftaroline versus Vancomycin as First-Line Therapy for MRSA Bacteremia

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8644109

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8644109

Other Identifiers

ISSN

2328-8957

E-ISSN

2328-8957

DOI

10.1093/ofid/ofab466.1431

How to access this item